Julian R. Molina
WinnMed(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial(2015)6,477 cited
- → Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship(2008)3,066 cited
- → Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment(2019)2,171 cited
- → Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials(2019)815 cited
- → Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers(2008)573 cited
- → Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2021)440 cited
- → Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study(2010)414 cited
- → The Ras/Raf/MAPK Pathway(2006)301 cited
- → NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018(2018)296 cited